Cargando…

Acquisition of TCF3 and CCND3 Mutations and Transformation to Burkitt Lymphoma in a Case of B-Cell Prolymphocytic Leukemia

Detalles Bibliográficos
Autores principales:	Nguyen-Khac, Florence, Bouzy, Simon, Roos-Weil, Damien, Bravetti, Clotilde, Maillon, Agathe, Diop, M’boyba, Doualle, Cécile, Droin, Nathalie, Bernard, Olivier A., Chapiro, Elise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096467/ https://www.ncbi.nlm.nih.gov/pubmed/33969276 http://dx.doi.org/10.1097/HS9.0000000000000563

Ejemplares similares

Successful treatment of an EBV‐positive HIV‐associated polymorphic B‐cell lymphoproliferative disorder by rituximab monotherapy
por: Sabbah, Mohamad, et al.
Publicado: (2021)

P596: DELETION OF THE SHORT ARM OF CHROMOSOME 8 AND TNFRSF10B LOSS ASSOCIATE TO POOR PROGNOSIS AND DRUG RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Jondreville, Ludovic, et al.
Publicado: (2023)

P600: DNA METHYLATION ANALYSIS OF B-CELL PROLYMPHOCYTIC LEUKEMIA REVEALS TWO EPIGENETIC SUBTYPES WITH DISTINCT BIOLOGICAL AND CLINICAL FEATURES
por: Charalampopoulou, Stella, et al.
Publicado: (2023)

Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation
por: Forgeard, Nathalie, et al.
Publicado: (2022)

NF-κB signaling controls H3K9me3 levels at intronic LINE-1 and hematopoietic stem cell genes in cis
por: Pelinski, Yanis, et al.
Publicado: (2022)

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
por: Algrin, Caroline, et al.
Publicado: (2022)

Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages
por: Bencheikh, Laura, et al.
Publicado: (2019)

A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset
por: Selimoglu-Buet, Dorothée, et al.
Publicado: (2018)

TCF3-HLF-Positive Acute Lymphoblastic Leukemia Resembling Burkitt Leukemia: Cell Morphologic and Immunophenotypic Findings
por: Li, Meng-Ju, et al.
Publicado: (2022)

Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre‐leukaemic clone resulting in T2‐ALL and AML‐M0
por: Manchev, Vladimir T., et al.
Publicado: (2016)

T-cell Prolymphocytic Leukemia, Cerebriform Variant
por: Carvalho, José, et al.
Publicado: (2021)

Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
por: Rohde, Marius, et al.
Publicado: (2017)

The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation
por: Buart, Stéphanie, et al.
Publicado: (2021)

DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice
por: Scourzic, Laurianne, et al.
Publicado: (2016)

T-cell Prolymphocytic Leukemia Presenting as Red Eye
por: Alwadani, Fahad
Publicado: (2011)

Advances in the understanding and management of T-cell prolymphocytic leukemia
por: Laribi, Kamel, et al.
Publicado: (2017)

An illustrative case of B-cell prolymphocytic leukemia
por: Jain, Ankur, et al.
Publicado: (2020)

Bilateral tonsillar infiltration of T‐cell prolymphocytic leukemia
por: Bertaggia, Ilaria, et al.
Publicado: (2019)

Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia
por: Kornauth, Christoph, et al.
Publicado: (2021)

Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia
por: Varadarajan, Indumathy, et al.
Publicado: (2022)

De-Novo B-Cell Prolymphocytic Leukemia
por: Menakuru, Sasmith R., et al.
Publicado: (2023)

T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment
por: Gutierrez, Marc, et al.
Publicado: (2023)

CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression
por: Zheng, Lixin, et al.
Publicado: (2018)

Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis
por: Dong, Lihua, et al.
Publicado: (2021)

An Association Between Hypoplastic Myelodysplastic Syndrome and T-Prolymphocytic Leukaemia
por: Arathi, C A, et al.
Publicado: (2011)

T-cell Prolymphocytic Leukemia with Cutaneous Involvement as the Presenting Feature
por: Ashturkar, Amrut V, et al.
Publicado: (2012)

T‐cell prolymphocytic leukemia and tuberculosis: a puzzling association
por: Cervera, Pascale, et al.
Publicado: (2017)

SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
por: Johansson, Patricia, et al.
Publicado: (2018)

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
por: Hampel, Paul J., et al.
Publicado: (2021)

T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches
por: Colon Ramos, Ana, et al.
Publicado: (2021)

Myeloid malignancies with translocation t(4;12)(q11‐13;p13): molecular landscape, clonal hierarchy and clinical outcomes
por: Parinet, Vincent, et al.
Publicado: (2021)

Bullous leukemia cutis in a patient with T-cell prolymphocytic leukemia
por: Siu, Sarah Y., et al.
Publicado: (2016)

Small cell variant of T-cell prolymphocytic leukemia with atypical presentation
por: Park, Joowon
Publicado: (2018)

Auer Rod-Like Inclusions in B-Cell Prolymphocytic Leukemia
por: Zhao, Yantian, et al.
Publicado: (2019)

Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia
por: Tian, Shulan, et al.
Publicado: (2021)

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Braun, Till, et al.
Publicado: (2021)

Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis
por: Geres, Hana, et al.
Publicado: (2023)

CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia
por: Ketzer, Franz, et al.
Publicado: (2022)

Rhodococcus equi Infection after Alemtuzumab Therapy for T-cell Prolymphocytic Leukemia
por: Meeuse, Jan J., et al.
Publicado: (2007)

Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
por: Liao, Hongyan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2qib5qu9budg93t1n1pul0in5p